Status:
RECRUITING
Effect of BT and PFET on Urinary Symptoms and Quality of Life in Patients With OABS
Lead Sponsor:
Hacettepe University
Conditions:
Overactive Bladder Syndrome (OABS)
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The aim of this study was to examine the effects of bladder training and pelvic floor exercise training programs given in addition to Botulinum Toxin-A (BTx-A) application on urinary symptoms and qual...
Eligibility Criteria
Inclusion
- over the age of 18 (those with a Mini Mental Test score of 24 and above for individuals over the age of 65),
- Who has Non-Neurogenic Overactive Bladder Syndrome,
- Patients who received Routine Botulinum Toxin-A administration because they did not respond to conservative treatment,
- Patients who volunteer to participate in the study will be included.
Exclusion
- Patients with Neurogenic Overactive Bladder Syndrome,
- Pregnant Women,
- Lack of cooperation in evaluation and/or treatment and lack of literacy status,
- Patients with urogynocological/anatomical abnormalities,
- Patients receiving pelvic radiation therapy,
- Patients with psychiatric or neurogenic disorders and
- Patients who have not given consent to the study and do not have an informed consent form (BGOF).
Key Trial Info
Start Date :
October 15 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 15 2024
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT06209333
Start Date
October 15 2023
End Date
October 15 2024
Last Update
January 17 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Aslı Aslan
Ankara, Turkey (Türkiye), 06100